Anatomic Pathology Industry Overview:
The anatomic pathology market is
projected to reach USD 49.1 billion by 2026 from USD 35.1 billion in 2021, at a
CAGR of 7.0%. The growth of the anatomical pathology market is primarily driven
by the high incidence of cancer and other target diseases, cancer screening
recommendations, reimbursement possibilities, and growing interest in
personalized medicine.
Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=137323145
Anatomic pathology products and services are used
in oncology drug trials to analyze quantitative information, detect
morphological structures, detect pharmacodynamic markers, and understand drug
mechanisms. It is also used to stratify trial subjects based on the responses
given by tissues to the drugs.
Globally, the COVID-19 outbreak has impacted every
aspect of the diagnostics industry, including the anatomic pathology industry.
In the last few months, the number of patient visits to hospitals has reduced
significantly, despite emergency and OPD services being available in hospitals.
Anatomic Pathology Services segment accounted for
the largest share of the global anatomic pathology market
Based on product & service, the anatomic
pathology market is segmented into services, consumables, and instruments. The
services segment accounted for the largest market share
By Application, disease diagnostics accounted for
the largest market share
Based on application, the anatomic pathology market
is segmented into disease diagnostics and medical research. The disease
diagnostics segment accounted for a larger share of the market.
By End User, Hospital laboratories accounted for
the largest market share
Based on end user, the anatomic pathology market is
segmented into hospital laboratories, clinical laboratories, and other end
users. Hospital laboratories accounted for the largest share.
North America dominates the anatomic pathology
market
North America accounted for the largest share of
the anatomic pathology market. Factors such as the rising prevalence of chronic
diseases, increasing healthcare expenditure, the high-quality infrastructure
for hospitals and clinical laboratories, and the presence of major market
players in the region are driving the growth of the anatomic pathology market
in North America.
Some prominent players in the global anatomic pathology market Include:
The major players in the anatomic pathology market
are F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and PHC
Holdings Corporation (Japan).
Anatomic Pathology Market
Segmentation
MarketsandMarkets has segmented the Anatomic Pathology Market based on Product
Type, End User application, and region:
By Product and Service
By Application
By End User
Region